Thomas Chalberg, Genascence

Gene ther­a­pies in the knee? With the help of a small herd of hors­es, a new start­up hopes to crack os­teoarthri­tis

Run­ning pre­clin­i­cal an­i­mal stud­ies in mice, rats and rab­bits is par for the course in biotech, but hors­es? Usu­al­ly too big and too ex­pen­sive. But …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

Director of IT, Security

Viridian Therapeutics

Waltham, MA, USA